Boston Scientific Corp. (NYSE:BSX) was on the rise Wednesday after posting first-quarter results that beat expectations. The Marlborough, Mass.-based company also reported that it was raising its 2018 revenue guidance range to $9.75 billion to $9.9 billion, up from a predicted $9.65 billion to $9.8 billion. The company closed at $29.42 after opening at $28.35. Read More
